Magnetar Financial LLC
Q2 2022 13F-HR Holdings
Net value change ($000)
+295,567
(3.2%)
New positions
461
Sold out positions
330
Turnover %
47.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VAL | 953,610 | NEW |
| VMWA | 146,006 | NEW |
| Black Knight, Inc. | 132,502 | 3088.6% |
| DUKE REALTY CORP | 108,849 | NEW |
| YRI | 96,300 | NEW |
| Biohaven Pharmaceutical Holding Co Ltd. | 86,146 | NEW |
| Turning Point Therapeutics, Inc. | 69,499 | NEW |
| Sierra Oncology, Inc. | 60,855 | NEW |
| GSK | 41,092 | 140.3% |
| LHC Group, Inc | 40,633 | 42.8% |
Top Reduces (Value $000, Stocks/ETFs)
| CERNER Corp | -186,241 | -100.0% |
| People's United Financial, Inc. | -129,697 | -100.0% |
| MGM Growth Properties LLC | -124,422 | -100.0% |
| ZYNGA INC | -122,570 | -100.0% |
| FERRO CORP | -109,364 | -100.0% |
| ECOL | -97,470 | -100.0% |
| Arriver Holdco, Inc. | -92,771 | -100.0% |
| AIY | -79,236 | -43.7% |
| FHN | -72,433 | -42.0% |
| Intersect ENT, Inc. | -71,082 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
47,250
(0.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|